News|Articles|October 26, 2023

Infection Intel: Moderna, CBIC, Helocyte, Pfizer, UVDI, and CloroxPro

Staying Ahead With Company Updates and Product Innovations. This week's news is from Moderna, CBIC, Helocyte, Pfizer, UVDI, and CloroxPro.

Infection Intel is a new column for Infection Control Today® (ICT®) that will cover the latest news, including updates on product developments, mergers, and more from companies in the infection control and prevention field.

Newsletter

Stay prepared and protected with the Infection Control Today newsletter, delivering essential updates, best practices, and expert insights for infection prevention professionals.

Subscribe

Related Content

Latest CME

Video

A Shield of Protection: Unmet Needs in COVID-19 Prevention and Control

Onyema Ogbuagu, MD, FACP, FIDSA; Jeffery A. Goad, PharmD, MPH; William P. Hanage, PhD

Multimedia

Empowering HIV Management: Evidence-Based Prevention and Treatment Strategies

Onyema Ogbuagu, MD, FACP, FIDSA

Infection Intel: Moderna, CBIC, Helocyte, Pfizer, UVDI, and CloroxPro

Related Content

FDA Says False-Positive Test Does Not Change Cyclospora Outbreak Investigation

Beyond Sterility: Why Coordination Is Becoming the New Measure of Sterile Processing Performance

Cyclospora Outbreak Continues: Expert Explains Symptoms, Testing, and Prevention

FDA and CDC Trace Cyclospora Outbreak to Taco Bell Lettuce as Investigation Continues

Weekly Rounds: Cyclosporiasis, Bundibugyo Ebola, and More